Milne Jill C. 4
4 · Astria Therapeutics, Inc. · Filed Mar 25, 2025
Insider Transaction Report
Form 4
Milne Jill C.
DirectorCEO and President
Transactions
- Award
Stock Option (Right to Buy)
2025-03-21+761,000→ 761,000 totalExercise: $6.41Exp: 2035-03-20→ Common Stock (761,000 underlying)
Footnotes (1)
- [F1]This option was granted on March 21, 2025 and is subject to vesting over a four-year period, with 25% of the 761,000 shares underlying the option upon grant vesting on the first anniversary of February 13, 2025 and the remainder vesting over the ensuing three years in equal monthly installments.